Impact of Helicobacter pylori Eradication on Circulating Adiponectin in Humans

The relationship between Helicobacter pylori infection and metabolic syndrome is not well understood. Adiponectin is an adipose‐derived protein considered to play a significant role in the development of metabolic syndrome. The aim of this study was to clarify the influence of H. pylori infection on circulating adiponectin in humans.

[1]  Takayuki Matsumoto,et al.  Possible association of atrophic gastritis and arterial stiffness in healthy middle-aged Japanese. , 2009, Journal of atherosclerosis and thrombosis.

[2]  M. Rizzetto,et al.  Clinical and biochemical parameters related to cardiovascular disease after Helicobacter pylori eradication. , 2009, International angiology : a journal of the International Union of Angiology.

[3]  T Nakamura,et al.  Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.

[4]  M. Membrez,et al.  Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  W. März,et al.  Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol. , 2004, The American journal of cardiology.

[6]  M. Demir,et al.  Effect of Helicobacter pylori Eradication on Insulin Resistance, Serum Lipids and Low-Grade Inflammation , 2010, Southern medical journal.

[7]  R. Gillum.  Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey. , 2004, Journal of the National Medical Association.

[8]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[9]  Kazuhide Higuchi,et al.  Long-term effect of Helicobacter pylori eradication on quality of life, body mass index, and newly developed diseases in Japanese patients with peptic ulcer disease. , 2002, Hepato-gastroenterology.

[10]  P. Scherer,et al.  Secretion of the Adipocyte-Specific Secretory Protein Adiponectin Critically Depends on Thiol-Mediated Protein Retention , 2007, Molecular and Cellular Biology.

[11]  I. Olafsson,et al.  Infections and obesity: A multinational epidemiological study , 2008, Scandinavian journal of infectious diseases.

[12]  J. Danesh,et al.  Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study , 1999, BMJ.

[13]  T. Saruta,et al.  Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. , 2002, Clinical science.

[14]  Ting Wang,et al.  The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Ishihara,et al.  Cardiovascular Risk Factors in Subjects with Helicobacter pylori Infection , 2002, Helicobacter.

[16]  J. Vandenbroucke,et al.  Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori. , 1995, Gut.

[17]  D. Rothenbacher,et al.  Helicobacter pylori heat shock protein 60 and risk of coronary heart disease: a case control study with focus on markers of systemic inflammation and lipids. , 2001, Atherosclerosis.

[18]  H. Randeva,et al.  Plasma ghrelin following cure of Helicobacter pylori. , 2003, Gut.

[19]  B. Longo-Mbenza,et al.  Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. , 2007, International journal of cardiology.

[20]  J. Danesh,et al.  Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. , 2000, Circulation.

[21]  K. Kario,et al.  Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients. , 2009, Atherosclerosis.

[22]  P. Froguel,et al.  Impaired Multimerization of Human Adiponectin Mutants Associated with Diabetes , 2003, Journal of Biological Chemistry.

[23]  Masato Kasuga,et al.  [Obesity and insulin resistance]. , 2009, Nihon rinsho. Japanese journal of clinical medicine.

[24]  F. Nardi,et al.  Increased thrombin generation and circulating levels of tumour necrosis factor‐α in patients with chronic Helicobacter pylori‐positive gastritis , 2004, Alimentary pharmacology & therapeutics.

[25]  E. Mezones-Holguín,et al.  In patients with type 2 diabetes mellitus, are glycosylated hemoglobin levels higher for those with Helicobacter pylori infection than those without infection? , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[27]  J. Hoekstra,et al.  High seroprevalence ofHelicobacter pylori in diabetes mellitus patients , 1996, Digestive Diseases and Sciences.

[28]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[29]  J. Hoekstra,et al.  High seroprevalence ofHelicobacter pylori in diabetes mellitus patients , 1996, Digestive Diseases and Sciences.

[30]  M. Päivänsalo,et al.  Interactions between ghrelin, leptin and IGF-I affect metabolic syndrome and early atherosclerosis , 2008, Annals of medicine.

[31]  S. Kihara,et al.  Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice , 2002, Circulation.

[32]  Y. Sugisaki,et al.  Effect of Helicobacter pylori Infection on Ghrelin Expression in Human Gastric Mucosa , 2004, The American Journal of Gastroenterology.

[33]  T. Ogihara,et al.  Association of Hypoadiponectinemia With Impaired Vasoreactivity , 2003, Hypertension.

[34]  Y. Matsuzawa,et al.  Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. , 1987, Metabolism: clinical and experimental.

[35]  J. Danesh,et al.  Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies , 1998, BMJ.

[36]  P. Della Monica,et al.  Helicobacter pylori infection in type 2 diabetic patients. , 2000, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[37]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[38]  M. Matsuda,et al.  PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.

[39]  O. Shawky,et al.  Vascular risks and complications in diabetes mellitus: the role of helicobacter pylori infection. , 2008, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[40]  Hajime Sato,et al.  Helicobacter Pylori Infection Is Significantly Associated With Metabolic Syndrome in the Japanese Population , 2008, The American Journal of Gastroenterology.

[41]  T. Yoshikawa,et al.  Helicobacter pylori infection and arterial stiffness in patients with type 2 diabetes mellitus. , 2008, Metabolism: clinical and experimental.

[42]  J. Halaas,et al.  Leptin and the regulation of body weight in mammals , 1998, Nature.

[43]  T. Funahashi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .

[44]  John A Wagner,et al.  Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity* , 2004, Journal of Biological Chemistry.